Waaxda Caalamiga ah

Juun 11, Kelun-Biotech waxay ku dhawaaqday in daawada TROP2 ADC ee si madax-bannaan loo sameeyay ee sac-TMT (佳泰莱), oo ay weheliso antibody-ga monoclonal PD-L1 tagitanlimab (科泰莱"), ay siisay Xarunta Qiimaynta Daawada (CDE) ee Xarunta Qaranka...Akhriso wax dheeraad ah»

Maajo 29, Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ayaa ansixiyay suuqgeynta Zanidatamab, oo ay soo gudbisay BeiGene, si loogu daaweeyo bukaanada qaba kansarka marinnada biliary-ga ee aan la daaweyn karin ama kansarka xuubka biliary-ga ee aan la daaweyn karin (BTC) kuwaas oo hore u helay daaweyn nidaamsan isla markaana muujiyay HER2 sare...Akhriso wax dheeraad ah»

Juun 04, 2025, Akeso waxay ku dhawaaqday in Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) uu ansixiyay antibody-ga PD-1/CTLA-4 ee heerka koowaad ee shirkadda, cadonilimab, si loogu daaweeyo kansarka ilmo-galeenka ee joogtada ah, soo noqnoqda, ama kansarka faafa, iyadoo lala kaashanayo platinum...Akhriso wax dheeraad ah»

Maajo 29, Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ayaa ansixiyay isku-darka daawada antibody-drug conjugate (ADC) trastuzumab rezetecan (SHR-A1811) ee HER2 ee lagu bartilmaameedsaday suuqgeynta. Waxaa loo tilmaamay inay tahay daaweyn hal-hal ah oo loogu talagalay daaweynta bukaanada qaangaarka ah ee aan la tirtiri karin ee maxalliga ah ama kuwa aan yar ahayn ...Akhriso wax dheeraad ah»

Maajo 21, 2025, InnoCare Pharma waxay ku dhawaaqday in Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) uu oggolaaday Minjuvi® (tafasitamab), oo ah daawo neefsasho oo Fc-modified cytolytic CD19 ah oo bartilmaameedsanaysa monoclonal antibody, oo lagu daray lenalidomide, oo ay ku xigto daaweynta Minjuvi monotherapy, si loogu daaweeyo...Akhriso wax dheeraad ah»

Maajo 22, 2025, Allist Pharmaceuticals ayaa ku dhawaaqday in dawadeeda cusub ee Airukai (Glecirasib Citrate Tablets), oo ah daawada joojisa KRAS-G12C, si rasmi ah loogu ansixiyay in suuqa lagu soo bandhigo Maamulka Badeecadaha Caafimaadka Qaranka (NMPA). Ansixinta ayaa u oggolaanaysa Airukai in loo isticmaalo daaweynta...Akhriso wax dheeraad ah»

Maajo 22, 2025, Kelun Bio waxay ku dhawaaqday in codsiga tilmaan cusub oo ku saabsan antigen-ka dusha sare ee unugyada trophoblast-ka ee 2 (TROP2) ee lagu hago antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, oo sidoo kale loo yaqaan SKB264/MK - 2870) (®) ay aqbashay Xarunta Qiimaynta Daawada (...Akhriso wax dheeraad ah»

Dagaalka Dheer ee ka dhanka ah Kansarka, Hubka Cusub ee Ka-hortagga Kansarka ayaa si joogto ah u soo baxaya, isagoo rajo cusub u keenaya Bukaannada Dagaalka daba dheeraaday ee u dhexeeya aadanaha iyo kansarka, hubka cusub ee ka-hortagga kansarka ayaa midba midka kale ka soo baxaya, taasoo rajo cusub u keenaysa bukaanada. Sida s cusub oo ifaya...Akhriso wax dheeraad ah»

Sannadkii 2021, bukaan 67 jir ah oo qaba kansarka ganaca ayaa abuuray mucjiso caafimaad. Ka dib markii ay la kulantay qalliin, dhowr wareeg oo kiimoterabi ah, iyo guuldarradii daaweynta TIL, tijaabadii caafimaad ee daaweynta unugyada TCR-T ee ay ka qayb qaadatay waxay ka dhigtay in metastases-ka sambabada ay hoos u dhacaan 72% 6 bilood gudahood...Akhriso wax dheeraad ah»

Maajo 12, 2025, CARsgen waxay ku dhawaaqday xog caafimaad oo hordhac ah oo loogu talagalay CT0596, oo ah CAR-T oo bartilmaameed u ah BCMA oo loo sameeyay iyadoo la adeegsanayo madal THANK-u Plus™. CT0596 hadda waxaa lagu qiimeynayaa daraasad caafimaad oo hore oo sahamin ah oo loogu talagalay myeloma badan oo soo noqnoqda/aan la qabsan karin (R/R MM) ama soo noqosho/celin...Akhriso wax dheeraad ah»

Maajo 9, 2025, Hansoh Pharmaceutical waxay ku dhawaaqday in tilmaam cusub oo loogu talagalay kiniiniyada Ameile (almonertinib mesylate) loo oggolaaday suuqgeynta. Tilmaamaha cusub waa daawaynta dheeraadka ah ee bukaanada qaangaarka ah ee qaba kansarka sambabada unugyada aan yarayn (NSCLC) oo burooyinka ay leeyihiin factor koritaanka epidermal dib u soo celinta...Akhriso wax dheeraad ah»

Maajo 1, 2025, Hansoh Pharmaceutical waxay ku dhawaaqday in daawada isku-darka ee B7-H4 ee kooxda iska soo saartay ee la beegsanayo antibody-drug conjugate (ADC) HS-20089 ee loogu talagalay duritaanka ay heshay oggolaansho lagu daro Daawaynta Degdegga ah oo ay soo saartay Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ee Shiinaha, oo...Akhriso wax dheeraad ah»